EU-1-00-131_h_w_dec_20.pdf@wrong_doctype@EU/1/00/131@PegIntron@https://ec.europa.eu/health/documents/community-register/2005/2005111510490/dec_10490_en.pdf
EU-1-00-156_h_a_dec_30.pdf@wrong_doctype@EU/1/00/156@Trizivir@https://ec.europa.eu/health/documents/community-register/2018/20180928142517/dec_142517_en.pdf
EU-1-02-217_h_a_dec_0.pdf@wrong_doctype@EU/1/02/217@Opatanol@https://ec.europa.eu/health/documents/community-register/2002/200205175233/dec_5233_en.pdf
EU-1-02-222_h_a_dec_28.pdf@wrong_doctype@EU/1/02/222@Tamiflu@https://ec.europa.eu/health/documents/community-register/2011/2011022198328/dec_98328_en.pdf
EU-1-03-252_h_a_dec_15.pdf@wrong_doctype@EU/1/03/252@Fuzeon@https://ec.europa.eu/health/documents/community-register/2008/2008070850934/dec_50934_en.pdf
EU-1-04-279_h_a_dec_21.pdf@wrong_doctype@EU/1/04/279@Lyrica@https://ec.europa.eu/health/documents/community-register/2010/2010042976570/dec_76570_en.pdf
EU-1-04-286_h_a_dec_2.pdf@wrong_doctype@EU/1/04/286@Wilzin@https://ec.europa.eu/health/documents/community-register/2009/2009101965529/dec_65529_en.pdf
EU-1-04-305_h_a_dec_19.pdf@wrong_doctype@EU/1/04/305@Truvada@https://ec.europa.eu/health/documents/community-register/2010/2010083187288/dec_87288_en.pdf
EU-1-06-334_h_a_dec_19.pdf@wrong_doctype@EU/1/06/334@Evoltra@https://ec.europa.eu/health/documents/community-register/2018/20181018142750/dec_142750_en.pdf
EU-1-06-370_h_a_dec_1.pdf@wrong_doctype@EU/1/06/370@Exforge@https://ec.europa.eu/health/documents/community-register/2008/2008060346088/dec_46088_en.pdf
EU-1-06-376_h_a_dec_8.pdf@wrong_doctype@EU/1/06/376@Irbesartan Zentiva@https://ec.europa.eu/health/documents/community-register/2011/20110607104488/dec_104488_en.pdf
EU-1-07-382_h_a_dec_7.pdf@wrong_doctype@EU/1/07/382@Xelevia@https://ec.europa.eu/health/documents/community-register/2009/2009102868410/dec_68410_en.pdf
EU-1-09-558_h_a_dec_3.pdf@wrong_doctype@EU/1/09/558@Clopidogrel BGR@https://ec.europa.eu/health/documents/community-register/2011/20111110112730/dec_112730_en.pdf
EU-1-09-564_h_a_dec_8.pdf@wrong_doctype@EU/1/09/564@Ilaris@https://ec.europa.eu/health/documents/community-register/2013/20130114125160/dec_125160_en.pdf
EU-1-12-757_h_a_dec_2.pdf@wrong_doctype@EU/1/12/757@Pioglitazone Teva@https://ec.europa.eu/health/documents/community-register/2014/20141216130256/dec_130256_en.pdf
EU-1-13-813_h_a_dec_3.pdf@wrong_doctype@EU/1/13/813@Perjeta@https://ec.europa.eu/health/documents/community-register/2015/20150728132547/dec_132547_en.pdf
EU-1-13-822_h_a_dec_3.pdf@wrong_doctype@EU/1/13/822@PHEBURANE@https://ec.europa.eu/health/documents/community-register/2018/20180321140127/dec_140127_en.pdf
EU-1-15-1006_h_a_dec_0.pdf@wrong_doctype@EU/1/15/100@Respreeza@https://ec.europa.eu/health/documents/community-register/2015/20150820132594/dec_132594_en.pdf
EU-1-15-1084_h_w_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/portrazza-epar-public-assessment-report_en.pdf
EU-1-16-1096_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/lonsurf-epar-public-assessment-report_en.pdf
EU-1-16-1167_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/truxima-epar-public-assessment-report_en.pdf
EU-1-17-1196_h_a_anx_2.pdf@corrupt@https://ec.europa.eu/health/documents/community-register/2020/20200428147712/anx_147712_en.pdf
EU-1-17-1218_h_a_public-assessment-report.pdf@corrupt@
EU-1-19-1374_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/esperoct-epar-public-assessment-report_en.pdf
EU-1-19-1376_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/libtayo-epar-public-assessment-report_en.pdf
EU-1-19-1399_h_a_dec_1.pdf@wrong_doctype@EU/1/19/139@Xospata@https://ec.europa.eu/health/documents/community-register/2021/20211209154035/dec_154035_en.pdf
EU-1-19-1404_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/rinvoq-epar-public-assessment-report_en.pdf
EU-1-20-1439_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/atectura-breezhaler-epar-public-assessment-report_en.pdf
EU-1-20-1441_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/bemrist-breezhaler-epar-public-assessment-report_en.pdf
EU-1-20-1454_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/aybintio-epar-public-assessment-report_en.pdf
EU-1-20-1455_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/piqray-epar-public-assessment-report_en.pdf
EU-1-20-1469_h_a_public-assessment-report.pdf@corrupt@
EU-1-20-1508_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/enhertu-epar-public-assessment-report_en.pdf
EU-1-21-1533_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/seffalair-spiromax-epar-public-assessment-report_en.pdf
EU-1-21-1542_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/copiktra-epar-public-assessment-report_en.pdf
EU-1-21-1565_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/ryeqo-epar-public-assessment-report_en.pdf
EU-1-21-1575_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/bimzelx-epar-public-assessment-report_en.pdf
EU-1-21-1597_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/regkirona-epar-public-assessment-report_en.pdf
EU-1-21-1600_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/tecovirimat-siga-epar-public-assessment-report_en.pdf
EU-1-21-1608_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/wegovy-epar-public-assessment-report_en.pdf
EU-1-22-1630_h_a_public-assessment-report.pdf@corrupt@
EU-1-22-1631_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/breyanzi-epar-public-assessment-report_en.pdf
EU-1-22-1667_h_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/vegzelma-epar-public-assessment-report_en.pdf
EU-1-95-001_h_a_dec_0.pdf@corrupt@EU/1/95/001@GONAL-f@https://ec.europa.eu/health/documents/community-register/1995/199510202830/dec_2830_en.pdf
EU-1-96-006_h_a_dec_0.pdf@wrong_doctype@EU/1/96/006@NovoSeven@https://ec.europa.eu/health/documents/community-register/1996/199602232878/dec_2878_en.pdf
EU-1-96-026_h_a_dec_27.pdf@wrong_doctype@EU/1/96/026@Invirase@https://ec.europa.eu/health/documents/community-register/2007/2007050223308/dec_23308_en.pdf
EU-1-97-047_h_a_dec_7.pdf@wrong_doctype@EU/1/97/047@BeneFIX@https://ec.europa.eu/health/documents/community-register/2002/200201234779/dec_4779_en.pdf
EU-1-97-055_h_a_dec_35.pdf@wrong_doctype@EU/1/97/055@Viramune@https://ec.europa.eu/health/documents/community-register/2009/2009052960048/dec_60048_en.pdf
EU-1-99-120_h_a_dec_21.pdf@wrong_doctype@EU/1/99/120@Ammonaps@https://ec.europa.eu/health/documents/community-register/2019/20190606145105/dec_145105_en.pdf
EU-1-99-123_h_a_dec_2.pdf@wrong_doctype@EU/1/99/123@Renagel@https://ec.europa.eu/health/documents/community-register/2001/200108094412/dec_4412_en.pdf
EU-3-05-339_o_w_dec_0.pdf@corrupt@EU/3/05/339@EU/3/05/339@https://ec.europa.eu/health/documents/community-register/2005/2005122310805/dec_10805_en.pdf
EU-3-09-665_o_w_dec_1.pdf@wrong_doctype@EU/3/09/665@EU/3/09/665@https://ec.europa.eu/health/documents/community-register/2013/20130725126376/dec_126376_en.pdf
EU-3-14-1300_o_a_public-assessment-report.pdf@corrupt@https://www.ema.europa.eu/documents/assessment-report/reblozyl-epar-public-assessment-report_en.pdf
